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Abstract
Introduction: dietary fat has been reported as one of the significant risk factors in the development of cardiovascular diseases (CVD). 
Objective: this study aimed at assessing the possible association between fat intake and CVD.
Methods: the present case-control study was conducted in the center of coronary angiography. Three-hundred and ninety nine patients who 
referred for elective coronary angiography with clinical suspicion of coronary artery disease were enrolled. Dietary data were collected from each 
patient using an interview-based food frequency questionnaire.
Results: the findings of the present study revealed no significant differences between cases and controls regarding the intake of all types of fat 
either before or after energy adjustment. For both cases and controls the percentage of fat intake from total energy and the intakes of polyun-
saturated and monounsaturated fats, cholesterol, omega-6 and omega-3 were within the recommended amounts. The intake of all fat types 
(except trans-fat) was not associated with the risk of developing CVD. Trans-fat intake in the second and third quartile increased the risk of CVD 
by OR 1.86 (95 % CI: 1.03-3.34) and 2.01 (95 % CI: 1.12-3.60), respectively.
Conclusions: while trans-fats may be significantly associated with the development of CVD in the first two quartiles, no association has been 
detected with other fat types.
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Resumen
Introducción: se ha establecido que la grasa en la dieta es uno de los factores de riesgo significativos en el desarrollo de enfermedades 
cardiovasculares (ECV).
Objetivo: este estudio tuvo como objetivo evaluar la posible asociación entre la ingesta de grasa y la ECV.
Métodos: el presente estudio de casos y controles se realizó en el centro de la angiografía coronaria. Se inscribieron 399 pacientes que fueron 
remitidos para una angiografía coronaria electiva con sospecha clínica de enfermedad coronaria. Los datos dietéticos se obtuvieron de cada 
paciente mediante un cuestionario de frecuencia de alimentos basado en entrevistas.
Resultados: los hallazgos del presente estudio no revelaron diferencias significativas entre los casos y los controles con respecto a la ingesta de 
todos los tipos de grasa, ya sea antes o después del ajuste de energía. Para ambos casos y controles, el porcentaje de ingesta de grasas de la 
energía total y las ingestas de grasas poliinsaturadas y monoinsaturadas, colesterol, omega-6 y omega-3 se encuentran dentro de las cantidades 
recomendadas. La ingesta de todos los tipos de grasa (excepto las grasas trans) no se asoció con el riesgo de desarrollar ECV. La ingesta de grasas 
trans en el segundo y tercer cuartil aumentó el riesgo de ECV en OR 1,86 (IC 95 %: 1,03-3,34) y 2,01 (IC 95 %: 1,12-3,60), respectivamente.
Conclusiones: si bien las grasas trans pueden estar asociadas significativamente con el desarrollo de ECV en los dos primeros cuartiles, no se 
ha detectado asociación con otros tipos de grasa. 
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INTRODUCTION
Cardiovascular disease (CVD) is the first cause of death and di sability 
worldwide (1). Unhealthy diet is a leading risk factor for CVD where 
several studies indicated that excessive consumption of sa turated fa-
tty acids (SFA) increases the low-density lipoprotein (LDL) cholesterol, 
which may enhance the risk of developing CVD (1-3). Eckel et al. 
(2014) reported strong evidence that redu cing SFA intake to 5-6 % of 
calories can be one important lifestyle modification for the manage-
ment of CVD, mainly by lowering LDL cholesterol (4). However, several 
studies that evaluated the association of fat intake with CVD are contro-
versial (5-8). Even though, for several decades, dietary guidelines have 
focused on the restriction of dietary cholesterol for heart health (5,6), 
numerous studies revealed that dietary cholesterol was not significantly 
associated with any coronary artery disease or ischemic stroke (7,8).
Epidemiological studies which examined the effect of monoun-
saturated fatty acids (MUFA) on CVD have shown mixed results. 
The Prevención con Dieta Mediterránea (PREDIMED) study reported 
that diets higher in MUFA reduced CVD events as compared with 
lower fat diets and, as a result, lowered the incidence of coronary 
heart disease (CHD) risk (9). Moreover, the Mediterranean dietary 
pattern, rich in MUFA, was recognized for its beneficial effects on 
CHD risk reduction in which a strong negative association was 
observed among followers of this dietary pattern and CHD risk 
(10). On the contrary, two meta analyses of cohort studies found 
no significant association between MUFA and CHD events or death 
(11,12). Several studies investigated the effect of polyunsaturated 
fatty acids (PUFA) and the risk of CVD and the obtained results 
were conflicting (13-15). A meta-analysis of randomized controlled 
trials showed that the increase in PUFA intake actually reduced 
the risk of CHD death (14,16). However, some prospective cohort 
studies have shown that PUFA increased the risk of cardiovascular 
outcomes (13) or were not associated with risk (15).
Consumption of trans-unsaturated fatty acids was associated with 
a 34 % increase in all-cause mortality, 28 % increased risk of CHD 
mortality, and 21 % increase in the risk of CHD (17). However, no 
associations were observed for ruminant trans-fat with CHD (17). 
This study aimed to explore the association between fat intake 
and the CVD risk in Jordan using a case-control design where a 
limited number of studies concerning risk factors for CVD has been 
published from the Middle East Countries. The concluded findings 
of this study would be of great importance for enhancing the public 
recognition about fat intake as a risk factor to develop CVDs. Those 
results could be used as a guidance to direct policy makers to initiate 
targeted nutritional and lifestyle strategies to prevent CVD events and 
alleviate their consequences. Also, those results could be used to 
establish more specified dietary guidelines regarding the intake of 
trans-fats and saturated fats for Jordanians.
SUBJECTS AND METHODS
PARTICIPANTS AND STUDY SETTING 
A case-control study was conducted to assess the association 
between fat intake and CVD risk among Jordanians. Participants 
of the present study were enrolled conveniently from the cathe-
terization section of the Cardiology Department of Prince Ham-
zah Hospital, a referral hospital in the capital Amman, between 
January and December 2015. A total of 399 participants who 
underwent coronary angiography were included. The cases and 
controls were age and gender matched with 1:1 ratio. Participants 
with kidney disease, liver disease or gastrointestinal diseases were 
excluded. All participants were requested to sign a written consent 
form to participate in the study. The study protocol was designed 
according to the ethical guidelines of the 1975 Declaration of 
Helsinki, and the study was approved by the Institutional Review 
Board Ethics Committee at Prince Hamzah Hospital. One day be-
fore undergoing coronary angiography, all data were collected 
from patients upon filling a standardized questionnaire by trained 
dietitians to record socio-demographic factors, previous health 
issues (hypertension, diabetes mellitus, dyslipidaemia), smoking 
status, and family history of CVDs information. 
CORONARY ANGIOGRAPHY
Seldinger technique was used to insert a catheter by trained 
cardiologists into the radial artery, and the tip was advanced to 
the aortic sinus cusp. To visualize the arterial tree, X-ray images 
of the transient radio-contrast distribution within the coronary 
arteries were carried out. The degree of obstruction was estima-
ted as percentage of the arterial lumen by comparing the area 
of narrowing to an adjacent normal artery. Consistent with prior 
studies, CAD was defined as ≥ 20 % stenosis of one or more 
coronary arteries (18,19). Participants with no stenosis (0 %) were 
enrolled as controls. 
NUTRIENTS INTAKE ASSESSMENT
A validated Arabic quantitative food frequency questionnaire 
(FFQ) was used to assess the dietary intake pattern (20). The 
information dealing with dietary history of participants was in-
vestigated in the FFQ questions. During face-to-face interviews, 
the participants were asked to record how frequently, on average, 
they had consumed one standard serving of specific food items 
in nine categories (< 1/month, 2-3/month, 1-2/week, 3-4/week, 
5-6/week, 1/day, 2-3/day, 4-5/day, or 6/day) during the past 
year. Food lists in the modified FFQ questions were classified 
based on types of food: 21 items of fruits and juices; 21 items of 
vegetables; eight items of cereals; nine items of milk and dairy 
products; four items of beans; 16 items of meat such as red 
meat (lamb and beef), chicken, fish, cold meat, and others; four 
items of soups and sauces; five items of drinks; nine items of 
snacks and sweets; and 14 items of herbs and spices. Food mo-
dels and standard measuring tools were used for better estimation 
of portion size. Dietary analysis software (ESHA Food Processor 
SQL version 10.1.1; ESHA, Salem, OR, USA) was used to analyze 
dietary intakes with additional data on foods consumed in Jordan. 
After entering the amounts which were consumed daily from the 
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raw fats, foods containing fats, fried foods and other foods to 
the ESHA program, total amounts of different fats were added 
and calculated. Recipes for Jordanian foods were entered and 
the total intake from these recipes was calculated. Energy (kcal), 
energy from fat (kcal), energy from saturated fat (kcal), energy 
from trans fatty acids (kcal), % of fat, fat (g), SFA (g), MUFA (g), 
PUFA (g), trans fat (g), cholesterol (mg), omega-3 (g), omega-6 (g), 
omega-3:omega-6, oleic (18:1) (g), linoleic (18:2) (g), lonolenic 
(18:3) (g), eicosen (20:1) (g), arachidon (20:4) (g), eicosapen-
taenoic acid (EPA) (20:5) (g), and docosapentaenoic acid (DPA) 
(22:5) (g) intake was assessed from the whole food items which 
are included in the used FFQ. 
7-DAY PHYSICAL ACTIVITY RECALL (PAR)
A 7-day PAR validated questionnaire, which is an organized 
questionnaire, was used to calculate a participant’s recall of time 
spent participating in exercise over a seven-day period (21). This 
questionnaire helps to divide individual physical activity levels into 
three categories. Participants were asked to respond to a PAR 
question based on the way they used to behave prior undergoing 
coronary angiography. 
ANTHROPOMETRIC MEASUREMENTS 
All anthropometric measurements were carried out by a trai-
ned dietitian. Body weight was measured to the nearest 0.1 kg, 
with minimal clothing and without shoes, using a calibrated scale 
(Seca®, Hamburg, Germany). Height and waist circumference 
were measured to the nearest 1 cm with participants in standing 
position without shoes using a calibrated portable measuring rod. 
Body mass index (BMI) was calculated as weight (kg) divided by 
height square (m2).
STATISTICAL ANALYSIS
SPSS version 20.0 software (SPSS Inc., Chicago, IL, USA) 
was used to perform the statistical analysis. The significance le-
vel was set at p ≤ 0.05. Mean ± standard error of mean (SEM) 
and percentages were used for descriptive statistics. To evaluate 
the differences between cases and controls in continuous varia-
bles, t-tests were used, and Chi-squared was used to detect the 
differences among categorical variables. Potential confounders 
(age, gender, BMI, smoking, physical activity, total energy intake, 
occupation, education level, marital status and family history) were 
chosen based on reported risk factors for CVDs. The quartiles 
were calculated using the cut-off points at 25, 50 and 75 % of 
total nutrients intake. The first quartile was determined if the in-
take was below 25 %, while the second one was determined if 
the intake was between 25-50 %. The third quartile was between 
50-75 % and the fourth was above 75 %. Multinomial logistic 
regression model and linear logistic regression model were used 
to calculate odd ratios (OR) and its 95 % confidence interval (CI) 
and p-for-trend for trend, respectively. The energy adjustment was 
performed using the residual method of Willett in which residuals 
were computed from a regression analysis (22). 
RESULTS
Briefly, 239 males and 160 females participated in this study. 
The study participants’ characteristics are shown in table I and 
have been as mentioned elsewhere (23). The main characteristics 
of study subjects categorized by gender are summarized in table I. 
The cases had higher mean fasting blood glucose levels compa-
red to controls. Moreover, cases showed higher blood triglyceride 
levels compared to controls. In addition, there were differences 
in physical activity measured as MET (min/week). Overall, the 
cases were less active compared to controls, and reported more 
previous health problems than controls, in both men and women.
Table II reveals that no significant difference was detected be-
tween cases and controls in all types of fat intake either before or 
after energy adjustment. Also, the percentage of fat intake from total 
energy was within the recommended level. How ever, the amount 
of saturated fat (around 30 g; 9.0 %) was close to the amount of 
MUFA (around 33 g; 10.5 %) which is not consistent with a healthy 
diet. On the other hand, the intake of PUFA (19 g; 6.0 %) was lower 
than both saturated and MUFA. The consumption of cholesterol 
was below the recommended amount (intake: 255 mg vs recom-
mended: 300 mg). Oleic fatty acid was the prominent type of fat 
among the cases and controls. Additionally, the intake of omega-6 
and omega-3 among cases and controls was in agreement with 
the recommended amounts. 
Table III shows the crude and adjusted ORs and their 95 % CI 
for CVD by fat types quartiles. OR and their 95 % CI for fat types 
were adjusted for age, gender, BMI, smoking, and physical activity. 
The intake of all fat types (except trans-fat) was not associated 
with the risk of developing CVD. Trans-fat intake in the second 
and third quartile increased the risk of CVD by adjusted for about 
1.86 (95 % CI: 1.03-3.34) and 2.01 odds (95 % CI: 1.12-3.60), 
respectively. Similar results of the association between trans-fat 
and CVD obtained was obtained for the crude OR.
DISCUSSION
This study aimed at evaluating the association between the 
intakes of different fat types and the development of CVD among 
Jordanians. Due to the discrepancy in the findings of multiple 
studies, the research is still unclear to judge if there is really 
a positive association between SFA and CVD, as traditionally 
speculated. The main findings of this study did not support the 
results of many other studies which stated that total dietary fats, 
saturated fats and cholesterol were positively associated with the 
risk of developing CHD (12,24,25). However, our findings came in 
agreement with several other studies (17,25,26). De Souza et al. 
(2015) reported null associations between saturated fat intake 
316 R. F. Tayyem et al.
[Nutr Hosp 2020;37(2):313-320]
Table I. General characteristics of study participants based on gender
Variable (mean ± SEM)
Male (n = 239) Female (n = 160)
Cases (n = 132) Controls (n = 107) Cases (n = 73) Controls (n = 87)
Age (y) 48.1 ± 0.5 48.4 ± 1.0 61.1 ± 1.2 54.1 ± 1.0
BMI (kg/m²) 29.9 ± 0.69 29.9 ± 0.56 31.9 ± 0.67 31.9 ± 0.50
Physical activity (MET/min) 11,289.5 ± 765.4 13,258.9 ± 752.7 7,539.9 ± 493.1 10,312.8 ± 682.8
Systolic blood pressure (mmHg) 130.8 ± 2.4 128.4 ± 2.3 142.9 ± 26.3 140.6 ± 23.9
Diastolic blood pressure (mmHg) 75.7 ± 0.98 78.8 ± 1.6 81.2 ± 1.7 80.5 ± 2.5
LDL (mg/dl) 109.8 ± 10.2 108.7 ± 9.5 110.0 ± 11.1 131.1 ± 17.2
HDL (mg/dl) 38.8 ± 2.78 39.5 ± 1.4 47.2 ± 3.4 48.40 ± 2.09
Triglycerides (mg/dl) 288.3 ± 45.8 163.1 ± 16.1 260.4 ± 47.9 176.3 ± 14.4
Cholesterol (mg/dl) 208.4 ± 16.8 186.4 ± 7.9 189.3 ± 9.7 215.0 ± 8.9
Fasting blood glucose (mmol/l) 8.7 ± 0.48 6.8 ± 0.31 10.5 ± 0.75 7.7 ± 0.42
Variable n (%)
Marital status
Married 128 (97.0) 103 (96.3) 57 (78.1) 77 (88.5)
Single 4 (3.0) 3 (2.8) 2 (2.7) 1 (1.1)
Divorced 0 (0.0) 1 (0.9) 1 (1.4) 2 (2.3)
Widowed 0 (0.0) 0 (0.0) 13 (17.8) 7 (8.0)
Education level
Illiterate 7 (5.3) 4 (3.7) 23 (31.5) 10 (11.5)
Primary education 54 (41.2) 47 (43.9) 35 (47.9) 36 (41.4)
Secondary education 41 (31.3) 30 (28.0) 12 (16.4) 23 (26.4)
Diploma 15 (11.5) 11 (10.3) 3 (4.1) 16 (18.4)
Bachelor 10 (7.6) 14 (13.1) 0 (0.0) 2 (2.3)
Postgraduate 4 (3.1) 1 (0.9) 0 (0) 0 (0)
BMI
Underweight 1 (0.8) 0 (0.0)
Normal 25 (18.9) 23 (21.5) 8 (11.0) 7 (8.0)
Overweight 61 (46.2) 32 (29.9) 23 (31.5) 18 (20.7)
Obese 45 (34.1) 52 (48.6) 42 (57.5) 62 (71.3)
Physical activity categories
Inactive 7 (5.3) 3 (2.8) 10 (13.7) 1 (1.1)
Minimally active 36 (27.3) 14 (13.1) 22 (30.1) 14 (16.1)
Health enhancing physical activity 89 (67.4) 90 (84.1) 41 (56.2) 72 (82.8)
Smoking
Yes 93 (70.5) 54 (50.5) 6 (8.2) 16 (18.4)
No 23 (17.4) 33 (30.8) 31 (42.5) 36 (41.4)
Previous 11 (8.3) 9 (8.4) 4 (5.5) 1 (1.1)
Passive 5 (3.8) 11 (10.3) 32 (43.8) 34 (39.1)
Health problem
Yes 91 (68.9) 60 (56.1) 69 (94.5) 71 (81.6)
No 41 (31.1) 47 (43.9) 4 (5.5) 16 (18.4)
Family history of CAD
Yes 52 (39.4) 28 (26.2) 31 (42.5) 42 (48.3)
No 80 (60.6) 79 (73.8) 42 (57.5) 45 (51.7)
*Significant difference was set at p < 0.05. SEM: standard error of mean; BMI: body mass index; MET: metabolic equivalent-minutes; LDL: low-density lipoprotein; 
HDL: high-density lipoprotein; CAD: coronary artery disease.
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Table II. Fat and type of intake of cases and controls before and after the adjustment 
of energy intake
Nutrients
Cases
(n = 205)
Controls
(n = 194)
p-value
Cases
(n = 205)
Controls
(n = 194)
p-value
Crude 
Mean ± SEM 
 Adjusted for energy 
Mean ± SEM 
Energy (kcal) 2,795.4 ± 68.1 2,914.1 ± 74.6 0.240 - - -
Energy from fat (kcal) 933.9 ± 26.2 964.2 ± 29.0 0.438 - - -
 % of fat 33.2 ±0.49 33.0 ± 0.49 0.719 - - -
 % Saturated fat 9.2 ± 0.19 9.1 ± 0.20 0.853
 % Monounsaturated fat 10.4 ± 0.23 10.6 ± 0.24 0.540
 % Polyunsaturated fat 6.2 ± 0.14 6.1 ± 0.14 0.585
 % Trans fat 0.17 ± 0.04 0.17 ± 0.04 0.970
Fat (g) 104.2 ± 2.9 107.6 ± 3.2 0.438 104.2 ± 1.4 107.6 ± 1.5 0.110
Saturated fat (g) 28.9 ± 0.94 30.5± 1.2 0.302 28.9 ± 0.56 30.5 ± 0.67 0.078
Monounsaturated fat (g) 32.5 ± 1.1 34.0 ± 1.1 0.316 30.5 ± 0.67 34.1 ± 7.4 0.878
Polyunsaturated fat (g) 19.2 ± 0.58 19.4 ± 0.63 0.738 19.1 ± 0.41 19.4 ± 0.47 0.648
Trans-fat (g) 0.55 ± 0.12 0.57 ± 0.14 0.897 0.55 ± 0.12 0.57 ± 0.14 0.897
Cholesterol (mg) 263.9 ± 13.2 252.7 ± 13.4 0.553 263.9 ± 11.4 252.7 ± 10.2 0.469
Omega-3 (g) 1.1 ± 0.03 1.1 ± 0.04 0.319 1.1 ± 0.03 1.1 ± 0.04 0.319
Omega-6 (g) 16.6 ± 0.53 16.7 ± 0.56 0.879 16.6 ± 0.40. 16.7 ± 0.44 0.845
Omega-3/Omega-6 0.07 ± 0.00 0.07 ± 0.00 0.448 0.07 ±0.002 0.07 ± 0.002 0.448
Oleic (18:1) (g) 30.4 ± 1.0 31.8 ± 1.0 0.318 30.4 ± 0.70 31.8 ± 0.72 0.150
Linoleic (18:2) (g) 16.5 ± 0.53 16.6 ± 0.56 0.864 16.5 ± 0.40 16.6 ± 0.44 0.826
Linolenic (18:3) (g) 0.98 ± 0.03 1.0 ± 0.03 0.287 0.98 ± 0.03 1.0 ± 0.03 0.287
Eicosen (20:1) (g) 0.16 ± 0.01 0.17 ± 0.01 0.714 0.16 ±0.01 0.17 ±0.01 0.714
Arachidon (20:4) (g) 0.14 ± 0.01 0.13 ± 0.01 0.202 0.14 ± 0.01 0.13 ± 0.01 0.202
Eicosapentaenoic acid (20:5) (g) 0.02 ±0.00 0.02 ± 0.00 0.828 0.02 ± 0.002 0.02 ± 0.002 0.828
Docosapentaenoic acid (22:5) (g) 0.01 ± 0.001 0.01 ± 0.001 0.604 0.01 ± 0.001 0.01 ± 0.001 0.604
and all-cause mortality (relative risk 0.99, 95 % CI: 0.91 to 1.09), 
CVD mortality (0.97, 0.84 to 1.12), total CHD (1.06, 0.95 to 
1.17), ischemic stroke (1.02, 0.90 to 1.15), and type 2 diabetes 
(0.95, 0.88 to 1.03) (17). Siri-Tarino et al. (2010) illustrated that 
the intake of saturated fat was not associated with an increased 
risk of CHD, stroke, or CVD; the pooled relative risk estimates that 
compared extreme quantiles of saturated fat intake were 1.07 
(95 % CI: 0.96, 1.19; p = 0.22) for CHD, 0.81 (95 % CI: 0.62, 
1.05; p = 0.11) for stroke, and 1.00 (95 % CI: 0.89, 1.11; 
p = 0.95) for CVD (25). Additionally, Harcombe et al. (2016) 
revealed that none of the studies included in their meta-analysis 
found a significant relationship between CHD deaths and total 
dietary fat intake (26). Factors such as food matrix, source of 
saturated fat, and fatty acid chain length may influence the health 
effects of saturated fats and therefore, might explain the contra-
diction in the current evidence regarding their association with 
CVD (27,28).
Although the 2015-2020 Dietary Guidelines for Americans re-
commend substituting both MUFA and PUFA for saturated fats, 
the consistency in the current evidence is lacking (27,28). Higher 
intakes of PUFA were found to be significantly associated with a 
lower risk of CHD comparing the highest and lowest quintile for 
PUFAs 0.80, (0.73 to 0.88; p-trend < 0.0001) (29). On contrary, 
Chowdury et al. (2014) reported no relationship between dietary 
PUFA and coronary disease, with a risk ratio 0.98 (CI: 0.90 to 
1.06) in eight cohort studies containing 206,376 participants 
with 8,155 events (12). The proportions among daily intake of 
different types of fat might provide a partial explanation for the 
inconsistent evidence concerning the association of unsaturated 
fats with CVD (30,31); the optimal balance among daily intake of 
different fatty acids can effectively improve the health while the 
incorrect ratio may increase disease risk (30,31). Here, no signifi-
cant association was detected between the intake of PUFA, MUFA, 
omega-6 or omega-3 and CVD risk among cases and controls. 
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Two main reasons might have contributed to the null findings; 
firstly, our study findings revealed that the intake of PUFA (around 
19 g/day; 6.0 %), MUFA (around 32 g/day; 10.5 %), omega-6 
fatty acid (16 g/day) and omega-3 fatty acid (1.1 g/day) was 
similar in cases and controls. Secondly, all of these types of fat 
were consumed in approximately the recommended doses (32). 
Trans-fat intake was found to be significantly associated with 
CVD among Jordanians, which is consistent with many studies 
(12,33). Trans-fats from foods may adversely affect the risk of 
coronary disease by raising LDL cholesterol levels and lowering 
high-density lipoprotein (HDL) cholesterol levels (34), increasing 
Lp(a) lipoprotein levels (34), raising triglyceride levels (34), and 
interfering with essential-fatty acid metabolism (35). Trans-fats 
were associated with all-cause mortality, total CHD, and CHD 
mortality, probably because of higher levels of intake of indus-
trial trans-fats than of ruminant trans-fats (17). Industrial and 
ruminant trans-fats consist of the same positional trans isomers, 
but in different proportions. The isomer profile depends on condi-
Table III. The OR (95 % CI) for nutrient intake among Jordanian participants
Nutrients Q1* Q2 Q3 Q4
Fat (g)
Cases number 57 56 45 47
Controls number 42 44 55 53
†Adjusted OR (95 % CI) 1 0.89 (0.50-1.60) 0.57 (0.32-1.03) 0.80 (0.44-1.45)
Crude OR (95 % CI) 1 0.94 (0.54-1.64) 0.60 (0.34-1.06) 0.65 (0.37-1.14) 
p-for-trend 0.358
Saturated fat (g)
Cases number 54 57 48 46
Controls number 45 43 53 53
†Adjusted OR (95 % CI) 1 1.07 (0.60-1.93) 0.77 (0.43-1.37) 0.90 (0.49-1.64)
Crude OR (95 % CI) 1 1.10 (0.63-1.93) 0.75 (0.43-1.32) 0.72 (0.41-1.27) 
p-for-trend 0.516
Monounsaturated fat (g)
Cases number 51 56 51 47
Controls number 48 45 49 52
†Adjusted OR (95 % CI) 1 1.08 (0.60-1.94) 0.85 (0.47-1.54) 0.78 (0.43-1.43)
Crude OR (95 % CI) 1 1.17 (0.67-2.04) 0.98 (0.56-1.71) 0.85 (0.49-1.49) 
p-for-trend 0.736
Polyunsaturated fat (g)
Cases number 51 56 44 54
Controls number 49 44 55 46
†Adjusted OR (95 % CI) 1 1.31 (0.73-2.33) 0.91 (0.51-1.64) 1.19 (0.67-2.13)
Crude OR (95 % CI) 1 1.22 (0.70-2.13) 0.77 (0.44-1.34) 1.13 (0.65-1.97) 
p-for-trend 0.361
Trans-fat (g)
Cases number 45 54 57 49
Controls number 61 42 42 49
†Adjusted OR (95 % CI) 1 1.86 (1.03-3.34) 2.01 (1.12-3.60) 1.38 (0.77-2.48)
Crude OR (95 % CI) 1 1.74 (1.00-3.04) 1.84 (1.06-3.20)  1.36 (0.78-2.36)
p-for-trend 0.311
Cholesterol (mg)
Cases number 50 57 47 51
Controls number 49 43 54 48
†Adjusted OR (95 % CI) 1 1.50 (0.83-2.69) 0.90 (0.50-1.62) 1.02 (0.56-1.86)
Crude OR (95 % CI) 1 1.30 (0.74-2.27) 0.85 (0.49-1.49) 1.04 (0.60-1.82)
p-for-trend 0.545
*Reference quartiles. †Adjusted for age, gender, BMI, smoking, physical activity, total energy intake, education level and family history.
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tions of hydrogenation, such as catalysts used and temperature 
of hydrogenation for industrial trans-fats and rumen pH, and 
the composition of oils in the diet for ruminant trans-fatty acids 
(36). Chowdhury et al. (2014) revealed in their meta-analysis 
that the intakes of SFA, MUFA, alpha-linoleic acid, long-chain 
omega-3 or omega-6 fatty acids were not associated with co-
ronary disease (12). However, they found that trans-fats increa-
sed the incidence of coronary disease (RR 1.16, 95 % CI: 1.06 
to 1.27) (12). Li et al. (2015) studied 84,628 women (Nurses’ 
Health Study, 1980 to 2010) and 42,908 men (Health Professio-
nals Follow-up Study, 1986 to 2010) who were free of diabetes, 
cardiovascular disease, and cancer at baseline, and found that 
trans-fat intake was significantly associated with an increased 
risk of CHD (HR: 1.20, 95 % CI: 1.09 to 1.32; p-trend = 0.002) 
(29). It has been estimated that the consumption of about 5 g of 
trans-fat per day is associated with 25 % increase in the risk of 
CHD (29). Although the association between CVD and trans-fat 
appears to be causal, no randomized controlled trial with hard 
endpoints has been reported (37).
Regarding cholesterol findings, our results showed no signifi-
cant association between the intakes of cholesterol and CVD risk, 
with insignificant difference in the mean intake of cholesterol for 
cases compared to controls. McNamara (2000) demonstrated in 
his review that the analysis of the available epidemiological and 
clinical data indicated that, for the general population, dietary cho-
lesterol makes no significant contribution to atherosclerosis and 
risk of cardiovascular disease (38). A recent study of Rhee et al. 
(2017) performed on 30,068 participants (mean age 40.8 years; 
84.5 % men) in a health screening program in Korea documented 
that dietary cholesterol intake did not show any association with 
LDL level or with risk for coronary artery calcification in apparently 
healthy Korean adults (39). The Scientific Report of the 2015 Die-
tary Guidelines Advisory Committee (DGAC) in the United States 
concluded that “cholesterol is not a nutrient of concern for over-
consumption”, suggesting that there no longer be a recommen-
ded upper limit for dietary cholesterol intake (40). This conclusion 
came after decades of the recommendation of 300 mg/d as the 
upper limit for dietary cholesterol. Despite eliminating the upper 
limit from the Dietary Guidelines, individuals should eat as little die-
tary cholesterol as possible as part of their healthy eating pattern 
to hinder CVD risk. Therefore, the lack of association between the 
dietary cholesterol and CVD in the current study could be due to 
the considerable low daily consumption of cholesterol (< 300 mg/
day) for both cases and controls. 
The main strength points of this study are the use of a validated 
Arabic FFQ that was modified to reflect the food consumption 
pattern in Arab countries, especially Jordan, as well as the use of 
food models and measuring tools to estimate portion sizes. There 
are limitations in this study; for example, the one year dietary 
recall period may not be an accurate amount of time in which to 
conclude that an association exists between fat intake and CVD 
development. Nevertheless, we believe that the recall period of 
one year is very likely reflective of the previous years. Thus, the 
association between fat dietary intake and CVD may have been 
developing for several years. 
In conclusion, no association has been found between choles-
terol, saturated fats, PUFA and MUFA and the risk of CVD. On the 
contrary, a significant association has been detected between 
trans-fats and the development of CVD. This may be attributed to 
the fact that the intake of most of these fat types (except trans-
fats) are within the recommended percentages and amounts. 
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